Inventor · disambiguated record
Jane Anne Healy
Also filed as: HEALY JANE · HEALY JANE ANNE
0 granted patents·7 pending applications·0 citations·filing 2011–2022
Top patents by PatentIndex Score
7 records- 0154US2021317214A1Combination therapy of a pd-1 antagonist and lag3 antagonist for treating patients with non-microsatellite instability-high or proficient mismatch repair colorectal cancerMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 0250US2021347889A1Dosing regimen of anti-lag3 antibody and combination therapy with anti-pd-1 antibody for treating cancerMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 0350US2025064794A1A therapeutic combination comprising a tigit antagonist, a pd-1 antagonist, and lenvatinibEISAI R&D MAN CO LTD·Filed 2022·Application pending·0 cites
- 0446US2024010729A1Combination therapy of a pd-1 antagonist and lag3 antagonist and lenvatinib or a pharmaceutically acceptable salt thereof for treating patients with cancerHEALY JANE ANNE·Filed 2021·Application pending·0 cites
- 0540US2023092707A1Methods for treating cancer or infection using a combination of an anti-pd-1 antibody, an anti-ctla4 antibody, and an anti-tigit antibodyMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 0635US2021403557A1Dosing regimen of anti-tigit antibody for treatment of cancerCAI MINGMEI·Filed 2019·Application pending·0 cites
- 0724US2013059778A1Identification of a Genetic Risk Factor for DiabetesBENNETT VANN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jane Anne Healy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →